Why Altimmune Is Crashing Today

Altimmune (NASDAQ: ALT) was plummeting in late trading on Wednesday, with the shares in free fall by nearly 40%. That was no surprise given the company's revelation the previous afternoon.

Just after market close on Tuesday, Altimmune officially threw in the towel on the development of its COVID-19 vaccine, AdCOVID. It's also halting enrollment on a phase 1/2 clinical trial of its T-COVID drug, which had been under way.

Image source: Getty Images.

Continue reading

Source Fool.com